Diagnosticos da America SA BMFBOVESPA:DASA3:
DENIES NEGOTIATIONS WITH REDE D'OR - STATEMENT
Brazil's Dasa Denies Negotiations With Rede D'Or
Diagnosticos da America S.A. on 6ix
Earlier from Diagnosticos da America
- Brazil's Dasa sells Mantris and Argentinian assets for 704.8 million reais
- Diagnósticos da América: Rede Américas JV cut net debt, boosted margins, and diagnostics led 5% revenue growth
- Diagnósticos da América: Dasa posted double-digit EBITDA growth and closed its transformative joint venture with Amil
- Diagnósticos da América: EBITDA up 11% to BRL 2.5B, leverage down, and operational focus drives margin gains
- Diagnósticos da América: EBITDA up 14% and leverage down 20% as margin focus and restructuring drive improvements
Later from Diagnosticos da America
- Diagnósticos da América: 3Q25 saw 12% Diagnostics revenue growth, 26.5% EBITDA margin, and leverage down to 2.38x
- Diagnósticos da América: Strong revenue, margin, and cash flow growth in 2025, with a positive outlook for 2026
- Diagnósticos da América: EBITDA up 28% and net income positive, with leverage and free cash flow significantly improved
- Diagnósticos da América: Strong Q1 growth in revenue, EBITDA, and cash flow, with premium and B2B segments leading
Follow Diagnosticos da America into a list and get an email when it puts out news.
Follow Diagnosticos da America